Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies. Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development and commercial stage products. Since inception, the firm has raised over $4 billion in capital and backed over 200 private and public portfolio companies. Vivo Capital is headquartered in Palo Alto, California, with offices in Beijing, Shanghai, Hong Kong, and Taipei.
Healthcare Focused Investment Firm:
Vivo Capital is a healthcare focused investment firm formed in 1996 that is currently making investments from its $1.4B Vivo Capital Fund IX into promising private healthcare companies, from its $635M Vivo Opportunity Fund into promising public healthcare companies, and from its $100M Vivo Innovation (PANDA) Fund into promising early-stage innovative healthcare companies.
Extensive Scientific Expertise:
With extensive scientific and clinical expertise and operating experience in healthcare, Vivo makes investment decisions for the Funds and helps its portfolio companies develop corporate strategy, facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth. Vivo’s historical portfolio includes more than 200 private and public companies in the areas of biopharmaceuticals, specialty pharmaceuticals, medical devices, and other subsectors of healthcare and life sciences.